In breast cancer, MHC‐II+ tumour cells in tumour‐draining lymph nodes (TDLNs) were found to lack costimulatory signals, thereby promoting regulatory T cell (Treg) expansion and suppressing CD4+ effector responses, ultimately facilitating lymph node metastasis.112. Here, CD4 is linked to breast carcinoma.